Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4552643 | 1.00 | LMNA (0.44) | LMNAMAPK1CYP2C9CYP2C19HSD17B10 | |
| Hydrochloric Acid SCHEMBL8340018 | 0.98 | LMNA (0.43) | LMNAMAPK1CYP2C9CYP2C19HSD17B10 | |
| SCHEMBL11543514 | 0.92 | LMNA (0.43) | LMNAMAPK1CYP2C9CYP2C19HSD17B10 | |
| SCHEMBL8754771 | 0.90 | CYP2C9 (0.50) | LMNAMAPK1CYP2C9CYP2C19HSD17B10 | |
| Glycolic Acid SCHEMBL9826127 | 0.90 | FFAR1 (0.44) | LMNAMAPK1CYP2C9CYP2C19HSD17B10 | |
| SCHEMBL11003311 | 0.82 | CYP2C9 (0.44) | LMNACYP2C9CYP2C19HSD17B10ALDH1A1 | |
| SCHEMBL11599061 | 0.82 | ALDH1A1 (0.42) | LMNAMAPK1FFAR1ALDH1A1SRC | |
| SCHEMBL28622779 | 0.80 | MEN1 (0.46) | LMNACYP2C9CYP2C19HSD17B10ALDH1A1 | |
| SCHEMBL28442743 | 0.80 | NAPRT (0.41) | LMNACYP2C9CYP2C19HSD17B10ALDH1A1 | |
| SCHEMBL10783459 | 0.80 | ALDH1A1 (0.53) | LMNACYP2C9CYP2C19HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | CHORDA PHARMA INC (US) | 2026-04-30 | — | — | US | claimed |
| US-20250228759-A1 | ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN | SEASPIRE INC (US) | 2025-07-17 | — | — | US | claimed |
| WO-2023078310-A1 | NUTRIENT SOLUTION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 长春圣博玛生物材料有限公司 | 2023-05-11 | — | — | WO | claimed |
| CN-116077358-A | Nutrient solution and preparation method and application thereof | 长春圣博玛生物材料有限公司 | 2023-05-09 | — | — | CN | claimed |
| WO-2023009502-A1 | ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN | SEASPIRE, INC. (US) | 2023-02-02 | — | — | WO | claimed |
| US-10219994-B2 | Method for the simultaneous permanent shaping and dyeing of keratinic fibers | HENKEL AG & CO. KGAA (DE) | 2019-03-05 | — | — | US | claimed |
| US-9943477-B2 | Emulsion compositions containing a novel preservative system | L'OREAL (FR) | 2018-04-17 | — | — | US | claimed |
| US-20180015060-A1 | HEALING TOPICAL COMPOSITION | FLORENGALE, LLC | 2018-01-18 | — | — | US | claimed |
| EP-3250196-A1 | HEALING TOPICAL COMPOSITION | Florengale, LLC (US) | 2017-12-06 | — | — | EP | claimed |
| EP-2361079-B1 | METHOD FOR DYEING AND SHAPING KERATIN FIBERS | HENKEL AG & CO KGAA (DE) | 2017-05-31 | — | — | EP | claimed |
| US-20050238681-A1 | Storage-stable compositions of glycerol monoalkyl ethers | SCHULKE & MAYR GMBH (DE) | 2005-10-27 | — | — | US | claimed |
| US-20030149097-A1 | Storage-stable compositions of glycerol monoalkyl ethers | ASHLAND SPECIALTIES DEUTSCHLAND GMBH (DE) | 2003-08-07 | — | — | US | claimed |
| EP-1301168-A1 | STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS | Air Liquide Santé (International) (FR) | 2003-04-16 | — | — | EP | claimed |
| WO-2001093825-A1 | STORAGE-STABLE COMPOSITIONS OF GLYCEROL MONOALKYL ETHERS | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2001-12-13 | — | — | WO | claimed |
| JP-2000512663-A | — | — | 2000-09-26 | — | — | JP | claimed |
| EP-1003469-A2 | FRAGRANCE PRECURSORS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2000-05-31 | — | — | EP | claimed |
| US-5925366-A | PERMEATION/BINDING AGENT, THIO CROSSLINKING AGENT, AND CHELATE COMPOUND | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1999-07-20 | — | — | US | claimed |
| US-5785959-A | MIXTURE CONTAINING A PERMEATION/BINDING AGENT, A THIO CROSSLINKING AGENT, A CHELATING AGENT, WATER AND AN OIL | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| WO-1998006376-A1 | NAIL STRENGTHENING COMPOSITIONS AND A METHOD FOR STRENGTHENING NAILS | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |
| WO-1997030687-A2 | FRAGRANCE PRECURSORS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1997-08-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015060-A1 | HEALING TOPICAL COMPOSITION | CUTA, CSDE1, SRI | LMNA 4598/4885MAPK1 3816/4885CYP2C9 2235/4885 |
| US-20260115155-A1 | STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN | TRPV1, SPTLC3, FFAR3 | LMNA 2375/4885MAPK1 2919/4885CYP2C9 1700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.